VITROS® diabetes solutions


Our innovative technology empowers clinicians to make better treatment decisions and improve the quality of life for diabetes patients of all ages. Our new VITROS® A1c solution revolutionizes how your lab can help clinicians treat patients.

Contact us
Diabetes is relentless

At the current growth rate, diabetes threatens to overwhelm global health care systems. The need for innovation and leadership in preventing and managing diabetes has never been more important.

 

Our comprehensive diabetes menu offers outstanding quality and accuracy, enabling your lab to do more with less and clinicians to better evaluate diabetes treatment options to improve patient care.


Watch: VITROS® A1c Solution

See how we're revolutionizing the way labs help clinicians treat patients

/

VITROS® A1c solution: A breakthrough design in whole blood testing*

Break free from the complexities of whole blood A1c testing with our novel enzymatic VITROS A1c slides and built-in intelligent technologies so that you can report A1c results confidently while increasing productivity and efficiency. 
 

*Not commercially available in the U.S., product availability subject to local regulatory requirements.

VITROS A1c slides have a multi-layered dry slide design that delivers exceptional performance. Certified by the National Glycohemoglobin Standardization Program (NGSP), it's free from hemoglobin variant interference.*

  • Less hands-on time
  • No separate pretreatment step to lyse red blood cells
  • Direct primary tube sampling
  • Extended walkaway time up to 20 minutes1

 

1. D48434 Whole Blood MicroSlide Processing Theory Guide

*Up to HbS ≤ 41%, HbC ≤ 36%, HbD ≤ 41%, HbE ≤ 40%


VITROS® Immunodiagnostic Products Insulin Reagent

The VITROS Insulin assay helps clinicians understand the cause of a patient’s hypoglycemia and differentiate between Type 1 and Type 2 diabetes. 

The VITROS Insulin assay antibody is highly specific for insulin detection, with no cross-reactivity to C-peptide or proinsulin.1 Importantly, it has insignificant or no cross-reactivity to insulin analogs commonly used in diabetes treatment.

1Ding, Qian. Performance Comparison of VITROS Immunodiagnostic Products Insulin Assay. Ortho Clinical Diagnostics PR-03149. 2017

Watch: Topics in HbA1c testing

Learn about the importance of HbA1c result standardization and how it is achieved by the National Glycohemoglobin Standardization Program (NGSP) to enable accurate HbA1c test results worldwide.

Presented by Randie R. Little, PhD, NGSP 
Network Laboratory Coordinator and Director, Diabetes Diagnostic Laboratory University of Missouri.


VITROS® diabetes assay menu


Vitros® diabetes assay menu